425 related articles for article (PubMed ID: 18080507)
1. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
[TBL] [Abstract][Full Text] [Related]
2. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
Bennett M; Schechter GP
Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
[TBL] [Abstract][Full Text] [Related]
3. [Splenic marginal zone lymphoma associated with antiphospholipid antibodies].
Yokoi T; Mori S; Sugimoto H; Komiyama Y; Uemura Y; Tanijiri R; Nakai K; Matsumoto N; Zen K; Amakawa R; Kishimoto Y; Ieko M; Takahashi H; Fukuhara S
Rinsho Ketsueki; 2004 Oct; 45(10):1095-9. PubMed ID: 15553043
[TBL] [Abstract][Full Text] [Related]
4. [Splenic marginal zone B-cell lymphoma with bilateral renal invasion after splenectomy].
Hoshino T; Iriuchijima H; Ogawa Y; Irisawa H; Jinbo T
Rinsho Ketsueki; 2008 Jan; 49(1):35-9. PubMed ID: 18277594
[TBL] [Abstract][Full Text] [Related]
5. Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia.
Fabbri A; Gozzetti A; Lazzi S; Lenoci M; D'Amuri A; Leoncini L; Lauria F
Clin Lymphoma Myeloma; 2006 May; 6(6):496-9. PubMed ID: 16796783
[TBL] [Abstract][Full Text] [Related]
6. Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients.
Iannitto E; Ambrosetti A; Ammatuna E; Colosio M; Florena AM; Tripodo C; Minardi V; Calvaruso G; Mitra ME; Pizzolo G; Menestrina F; Franco V
Cancer; 2004 Nov; 101(9):2050-7. PubMed ID: 15389479
[TBL] [Abstract][Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia.
Abramson JS; Chatterji M; Rahemtullah A
N Engl J Med; 2008 Dec; 359(25):2707-18. PubMed ID: 19092156
[No Abstract] [Full Text] [Related]
8. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
[TBL] [Abstract][Full Text] [Related]
9. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
[TBL] [Abstract][Full Text] [Related]
10. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma.
Vlădăreanu AM; Onisâi M; Ciufu C; Bumbea H; Cîşleanu D; Voican I; Nicolescu A; Radeşi S; Vintilescu A; Băluţă C; Dobrea C; Savlovschi C; Grecu L; Serban D; Serafim G
Rom J Intern Med; 2009; 47(2):191-9. PubMed ID: 20067170
[TBL] [Abstract][Full Text] [Related]
11. A case of splenic lymphoma with marked diffuse nodular fibrosis and calcification, complicated with severe autoimmune hemolytic anemia.
Yamazaki K
J Submicrosc Cytol Pathol; 2003 Jan; 35(1):17-23. PubMed ID: 12762647
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment with rituximab in a patient with splenic marginal zone B-cell lymphoma accompanied by cold agglutinin disease].
Yasuyama M; Kawauchi K; Otsuka K; Tamura H; Fujibayashi M
Nihon Ronen Igakkai Zasshi; 2014; 51(6):569-75. PubMed ID: 25749330
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
Fujita T; Asagoe K; Sakoda H
Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
[TBL] [Abstract][Full Text] [Related]
14. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
15. [Splenic marginal zone lymphoma complicated by cold agglutinin disease].
Ochi K; Yokoyama K; Ohno N; Ota Y; Tojo A
Rinsho Ketsueki; 2017; 58(2):132-137. PubMed ID: 28321090
[TBL] [Abstract][Full Text] [Related]
16. Primary splenic marginal zone lymphoma with florid granulomatous reaction--a case report and review of literature.
Manipadam MT; Viswabandya A; Srivastava A
Pathol Res Pract; 2007; 203(4):239-43. PubMed ID: 17398014
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hemolytic anemia as presenting manifestation of primary splenic anaplastic large cell lymphoma.
Köksal Y; Calişkan U; Uçar C; Erekul S; Ilerisoy Yakut Z
Turk J Pediatr; 2006; 48(4):354-6. PubMed ID: 17290572
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
[TBL] [Abstract][Full Text] [Related]
19. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
20. Rituximab monotherapy for splenic marginal zone lymphoma.
Bennett M; Sharma K; Yegena S; Gavish I; Dave HP; Schechter GP
Haematologica; 2005 Jun; 90(6):856-8. PubMed ID: 15951303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
